top of page

Kansas Republicans Reject Amendment To Grant Terminally Ill Patients The Right To Try Medical Marijuana

  • Writer: Bob Marley
    Bob Marley
  • Feb 21, 2025
  • 2 min read

“We’ve examined medical cannabis for quite some time, and the term medical cannabis is nothing but a marketing ploy.”

By Anna Kaminski, Kansas Reflector

A Senate Democrat unsuccessfully attempted to insert “medicinal cannabis” among treatments allowed under a bill meant to broaden Kansans’ access to experimental drugs.

Democratic Sen. Cindy Holscher, who introduced Wednesday the amendment that would have legalized medicinal cannabis for terminally ill patients, later emphasized her intention was not to create a public medical marijuana program.

“I think most of you realize I would not bring something of that magnitude to an important bill like SB 250,” said Holscher, of Overland Park, Wednesday evening. “That amendment, rather, was to mirror what was approved by President Trump in the Right to Try Act, which is a very defined, narrow scope only for terminally ill patients.”

Senate Bill 250, introduced and carried on the Senate floor by Eudora Republican Sen. Beverly Gossage, would create the Right to Try for Individualized Investigative Treatments Act. Investigational treatments can also be referred to as experimental drugs, according to the U.S. Food and Drug Administration.

The bill would permit people who are unable to find relief from rare, life-threatening or debilitating conditions to access individualized, genetics-based medical treatment. The drug trial evaluation system in the U.S. is designed to evaluate medications meant to help larger populations, leaving behind drugs that can be individually tailored to a patient’s unique genetic makeup, Gossage said.

“Individualized treatments are being pioneered in the U.S. and abroad, but often patients in the U.S. travel thousands of miles,” she said.

The bill passed the Senate and is awaiting approval in the House.

Holscher supported the bill as a whole but voiced concerns.

“I don’t want to give people false hope,” she said, “yet I certainly would not stand in the way of a parent or individual trying to get medical help for a family member.”

Her amendment added medicinal cannabis to the list of treatments allowed under the definition of individualized investigative treatment.

Cannabis “has been found to have proven benefits for those with life-threatening or debilitating diseases,” Holscher said.

During floor debate on the amendment, Sen. Mike Thompson, a Shawnee Republican who sat on the two-day 2024 interim committee that evaluated the possibility of medical marijuana in Kansas, said adding legislation opens a door to unintended consequences.

“We’ve examined medical cannabis for quite some time,” Thompson said, “and the term medical cannabis is nothing but a marketing ploy.”

Medical marijuana is legal in 39 states and Washington, D.C. Recreational use of marijuana is legal in 24 states and the District of Columbia.

In 2023, of the four proposed bills in Kansas related to medical marijuana, one received a hearing and died in committee. In 2024, two were introduced and both died in committee.

Gossage admonished Holscher’s amendment after nine Democrats voted in favor and all 31 Republicans voted against it.

“I just think it’s tragic that we would turn a discussion on a right to try for individualized treatment for patients with ultra-rare, life-threatening, debilitating diseases that could be life-saving to a debate on so-called medical marijuana,” she said. “That should be a completely separate bill.”

This story was first published by Kansas Reflector.

Thousands Of Kansas Residents Have Medical Marijuana Cards—From Neighboring Missouri

Recent Posts

See All

Comments


Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page